Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 4 , Pages 236-242 , May 2010

An NPC1L1 gene promoter variant is associated with autosomal dominant hypercholesterolemia

  • B. Martín

      Affiliations

    • Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, and Ciber Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Spain
    • ,
  • M. Solanas-Barca

      Affiliations

    • Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, I+CS, Zaragoza, Spain
    • ,
  • Á.-L. García-Otín

      Affiliations

    • Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, I+CS, Zaragoza, Spain
    • ,
  • S. Pampín

      Affiliations

    • Departamento de Biología Molecular, Facultad de Medicina, Universidad de Cantabria, Santander, Spain
    • ,
  • M. Cofán

      Affiliations

    • Unitat de Lípids, Servei d'Endocrinologia i Nutrició, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona and Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, Spain
    • ,
  • E. Ros

      Affiliations

    • Unitat de Lípids, Servei d'Endocrinologia i Nutrició, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, Barcelona and Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, Spain
    • ,
  • J.-C. Rodríguez-Rey

      Affiliations

    • Departamento de Biología Molecular, Facultad de Medicina, Universidad de Cantabria, Santander, Spain
    • ,
  • M. Pocoví

      Affiliations

    • Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, and Ciber Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Spain
    • ,
  • F. Civeira

      Affiliations

    • Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, I+CS, Zaragoza, Spain
    • Corresponding Author InformationCorresponding author. Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, Avda. Isabel La Católica, 1-3, 50009 Zaragoza, Spain. Tel.: +34 976765500; fax: +34 976369985.

Received 25 November 2008 ,Revised 19 March 2009 ,Accepted 20 March 2009.

References 

  1. Goldstein JL, Hobbs H, Brown MS. Familial hypercholesterolemia. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. 8th ed. The metabolic and molecular basis of inherited disease. vol. 2:New York: McGraw-Hill; 2001;p. 2863–2913
  2. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34:154–156
  3. Fouchier SW, Kastelein JJ, Defesche JC. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat. 2005;26:550–556
  4. Lammert F, Wang DO. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology. 2005;129:718–734
  5. Kesäniemi YA, Miettinen TA. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest. 1987;17:391–395
  6. García-Otín AL, Cofán M, Junyent M, Recalde D, Cenarro A, Pocoví M, et al. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes. J Clin Endocrinol Metab. 2007;92:3667–3673
  7. Altmann SW, Davis HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, et al. Niemann–Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201–1204
  8. Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, et al. Niemann–Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004;279:33586–33592
  9. Davies JP, Scott C, Oishi K, Liapis A, Ioannou YA. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem. 2005;280:12710–12720
  10. Davies JP, Levy B, Ioannou YA. Evidence for a Niemann–Pick C (NPC) gene family: identification and characterization of NPC1L1. Genomics. 2000;65:137–145
  11. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A. 2006;103:1810–1815
  12. Gómez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, Porres A, Rueda A, Avellaneda A, et al. DRECE study group Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. Med Clin. 1999;113:730–735
  13. Meriño-Ibarra E, Artieda M, Cenarro A, Goicoechea J, Calvo L, Guallar A, et al. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism. 2005;54:1230–1235
  14. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20–31
  15. Tejedor D, Castillo S, Mozas P, Jimenez E, Lopez M, Tejedor MT, et al. Spanish FH Group Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem. 2005;51:1137–1144
  16. Simon JS, Karnoub MC, Devlin DJ, Arreaza MG, Qiu P, Monks SA, et al. Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment. Genomics. 2005;86:648–656
  17. Mozas P, Galetto R, Albajar M, Ros E, Pocovi M, Rodriguez-Rey JC. A mutation (−49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. J Lipid Res. 2002;43:13–18
  18. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921–927
  19. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing data imputation. Am J Hum Genet. 2005;76:449–462
  20. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23:4878–4884
  21. Fahmi S, Yang C, Esmail S, Hobbs HH, Cohen JC. Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes. Hum Mol Genet. 2008;17:2101–2107
  22. Santosa S, Varady KA, AbuMweis S, Jones PJ. Physiological and therapeutic factors affecting cholesterol metabolism: does a reciprocal relationship between cholesterol absorption and synthesis really exist?. Life Sci. 2007;80:505–514
  23. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem. 2006;281:6616–6624
  24. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, et al. Hepatic Niemann–Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007;117:1968–1978
  25. Weston AD, Blumberg B, Underhill TM. Active repression by unliganded retinoid receptors in development: less is sometimes more. J Cell Biol. 2003;161:223–228
  26. Johnson AD, Wang D, Sadee W. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol Ther. 2005;106:19–38
  27. Smith AJ, Ahmed F, Nair D, Whittall R, Wang D, Taylor A, et al. A functional mutation in the LDLR promoter (−139C>G) in a patient with familial hypercholesterolemia. Eur J Hum Genet. 2007;15:1186–1189
  28. Rowntree R, Harris A. DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding. Hum Genet. 2002;111:66–74
  29. Civeira F, Ros E, Jarauta E, Plana N, Zambon D, Puzo J, et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol. 2008;102:1187–1193
  30. Meriño-Ibarra E, Puzo J, Jarauta E, Cenarro A, Recalde D, García-Otín AL, et al. Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia. J Inherit Metab Dis. 2007;30:970–977

PII: S0939-4753(09)00081-7

doi: 10.1016/j.numecd.2009.03.023

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 4 , Pages 236-242 , May 2010

Article Tools

* Image Usage & Resolution